Physician

Sharel C Ongchin, M.D.

According to 2025 Medicare claims, Sharel Ongchin, M.D. (NPI: 1538324694) practices ophthalmology in the Seattle-Bellevue-Kent, WA market, with the plurality of this provider's patient population coming from King, WA. This provider's primary affiliated billing organization is RETINA CONSULTANTS OF SEATTLE, PC (NPI: 1467566828; TIN: 912062004) and primary practice location at 98201-4139.

Ongchin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 595 traditional Medicare patients, billed 18,351 HCPCS/CPT codes, and received $1,150,760 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 697 prescription claims across 143 beneficiaries totaling $52,844 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 6 records totaling $240. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $45,826 to $52,844. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	476	5,165	$804,208
2016	565	6,948	$1,039,387
2017	609	7,412	$1,124,379
2018	681	7,899	$1,225,428
2019	691	7,575	$1,278,991
2020	611	5,987	$1,160,062
2021	460	4,730	$916,193
2022	581	7,343	$1,378,909
2023	613	15,653	$1,312,454
2024	595	18,351	$1,150,760

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	182	489	$45,826
2016	74	300	$20,745
2017	80	375	$25,494
2018	93	494	$32,875
2019	102	466	$43,116
2020	97	399	$37,315
2021	91	336	$37,014
2022	110	573	$49,676
2023	120	564	$47,913
2024	143	697	$52,844

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
67028	Injection of drug into eye	144	605	$103
92014	Established patient complete exam of visual system	354	481	$94
92012	Established patient problem focused exam of visual system	174	542	$81
92134	Imaging of retina	577	1,401	$35
92202	Extended exam of the back part of the eye with optic nerve drawing	406	599	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Restasis	Cyclosporine	32	1,305	$27,857
Prednisolone Acetate	Prednisolone Acetate	94	3,947	$4,474
Ketorolac Tromethamine	Ketorolac Tromethamine	99	3,959	$3,567
Simbrinza	Brinzolamide/Brimonidine Tart	12	360	$2,445
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	16	1,110	$2,421

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$240	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sharel C. Ongchin, M.D.?

Tedicare shows public-source Medicare data for Sharel C. Ongchin, M.D. (NPI 1538324694), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sharel C. Ongchin, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sharel C. Ongchin, M.D.?

Sharel C. Ongchin, M.D. is linked to RETINA CONSULTANTS OF SEATTLE, PC (billing NPI 1467566828) in the available physician profile data.

Does Sharel C. Ongchin, M.D. have Open Payments data?

Sharel C. Ongchin, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.